Posts Tagged ‘regulatory affairs’

Trying to get it right: a blog carnival about Right to Try

Author: Stacey Johnson, 08/29/17

The crux of Right to Try legislation, enacted by 37 U.S. states so far, is the premise that terminally ill patients should have access to experimental therapies, even if they haven’t been approved by the Food and Drug Administration yet. It sounds straight-forward right? My body, my risk, my decision. The U.S. already has measures…Read more

Taking appropriate steps towards gene editing in Canada

Author: Guest, 09/29/16

Patrick Bedford is the new Manager of Clinical Translation and Regulatory Affairs at CCRM.  He holds a Master’s Degree in Bioethics and Health Law, and has over 10 years of experience applying federal regulations to emerging biotechnologies in Canada.   Back in August, I had the pleasure of attending a gene editing/CRISPR workshop, hosted by…Read more